These findings suggest that CD14-expressing cancer cells promote neutrophil-recruiting chemokine production via NFκB activation, leading us to investigate whether this CD14–NFκB–chemokine axis observed in vitro is also recapitulated in vivo within the tumor microenvironment. This evidence concerns the gene NFKB1 and neoplasm.